Long-term morbidity in bipolar-I, bipolar-II, and unipolar major depressive disorders

Journal of Affective Disorders

Volumn 178, Issue , 2015, Pages 71-78

  Forte, Alberto ^a,b,c   Baldessarini, Ross J ^a,b   Tondo, Leonardo ^a,b,d,e   Vázquez, Gustavo H ^b,f   Pompili, Maurizio ^c   Girardi, Paolo ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Mailman Research Center   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Lucio Bini Mood Disorder Center   (Italy)

^e Lucio Bini Mood Disorders Center   (Italy)

^f UNIVERSITY OF PALERMO   (Argentina)

Author keywords

Bipolar Rfis1; Bipolar II; Long term; Major depression; Morbidity; Percent time ill

Indexed keywords

BIPOLAR I DISORDER; BIPOLAR II DISORDER; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; HUMAN; HYPOMANIA; MAJOR DEPRESSION; MANIA; MORBIDITY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR;

BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; HUMANS; MORBIDITY;

EID: 84925111390     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.02.011     Document Type: Review

References (76)

1. O.P. Almeida, G.J. Hankey, B.B. Yeap, J. Golledge, P.E. Norman, and L. Flicker Mortality among people with severe mental disorders who reach old age: longitudinal study of a community-representative sample of 37,892 men PLoS One 9 2014 e111882
2. American Psychiatric Association (APA) Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) 2013 American Psychiatric Press Washington, DC
3. J. Angst, and M. Preisig Outcome of a clinical cohort of unipolar, bipolar and schizoaffective patients: results of a prospective study from 1959 to 1985 (two parts) Schweiz. Arch. Neurol. Psychiatr. 146 1995 5 23
4. P. Arvilommi, K. Suominen, O. Mantere, S. Leppämäki, H. Valtonen, and E. Isometsä Predictors of adherence to psychopharmacological and psychosocial treatment in bipolar I or II disorders: 18-month prospective study J. Affect. Disord. 155 2014 110 117
5. R.J. Baldessarini Chemotherapy in Psychiatry 2013 Springer New York, NY
6. R.J. Baldessarini, P. Salvatore, H. Imaz-Etxeberria, H.-M.K. Khalsa, A. Gonzalés-Pinto, and M. Tohen Episode cycles with increasing recurrences in first-episode bipolar-I disorder patients J. Affect. Disord. 136 2012 149 154
7. R.J. Baldessarini, P. Salvatore, H.-M.K. Khalsa, P. Gebre-Medhin, H. Imaz, A. González-Pinto, J. Perez, N. Cruz, C. Maggini, and M. Tohen Morbidity in 303 first-episode bipolar I disorder patients Bipolar Disord. 12 2010 264 270
8. R.J. Baldessarini, P. Salvatore, H.-M.K. Khalsa, and M. Tohen Dissimilar morbidity following initial mania versus mixed-states in type-I bipolar disorder J. Affect. Disord. 126 2010 299 302
9. R.J. Baldessarini, L. Tondo, and B. Lepri Correlation of initial wellness with long-term morbidity in recurrent major affective disorder patients as a test of survival analysis J. Clin. Psychopharmacol. 30 2010 72 75
10. L. Berk, K.T. Hallam, F. Colom, E. Vieta, M. Hasty, C. Macneil, and M. Berk Enhancing medication adherence in patients with bipolar disorder Hum. Psychopharmacol. 25 2010 1 16
11. H. Brodaty, G. Luscombe, C. Peisah, K. Anstey, and G. Andrews A 25-year longitudinal, comparison study of the outcome of depression Psychol. Med. 31 2001 1347 1359
12. A. Cipriani, T.A. Furukawa, G. Salanti, J.R. Geddes, J.P. Higgins, R. Churchill, N. Watanabe, A. Nakagawa, I.M. Omori, H. McGuire, M. Tansella, and C. Barbui Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis Lancet 373 2009 746 758
13. W. Coryell, D. Solomon, A. Leon, J.G. Fiedorowicz, P. Schettler, L. Judd, and M. Keller Does major depressive disorder change with age? Psychol. Med. 39 2009 1689 1695
14. W. Coryell, D.A. Solomon, J.G. Fiedorowicz, J. Endicott, P.J. Schettler, and L.L. Judd Anxiety and outcome in bipolar disorder Am. J. Psychiatry 166 2009 1238 1243
15. M. Crowe, R. Porter, M. Inder, C. Lacey, D. Carlyle, and L. Wilson Effectiveness of interventions to improve medication adherence in bipolar disorder Aust. N. Z. J. Psychiatry 46 2012 317 326
16. M. Crowe, L. Wilson, and M. Inder Patients reports of the factors influencing medication adherence in bipolar disorder - an integrative review of the literature Int. J. Nurs. Stud. 48 2011 894 903
17. C. DeDios, E. Ezquiaga, A. Garcia, B. Soler, and E. Vieta Time spent with symptoms in a cohort of bipolar disorder outpatients in Spain: prospective, 18 month follow-up study J. Affect. Disord. 125 2010 74 81
18. Economist. The Global Crisis of Depression (symposium preceedings). London, November, 2014 [Accessible at http://www.economistinsights.com/healthcare.event/global-crisis-depression(accessed 2.02.15.)]
19. H. Fan, W. Yu, Q. Zhang, H. Cao, J. Li, J. Wang, Y. Shao, and X. Hu Depression after heart failure and risk of cardiovascular and all-cause mortality: meta-analysis Prev. Med. 63 2014 36 42
20. A. Fekadu, L.J. Rane, S.C. Wooderson, K. Markopoulou, L. Poon, and A.J. Cleare Prediction of longer-term outcome of treatment-resistant depression in tertiary care Br. J. Psychiatry 201 2012 369 375
21. A.J. Ferrari, F.J. Charlson, R.E. Norman, S.B. Patten, G. Freedman, C.J.L. Murray, T. Vos, and H.a. Whiteford Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010 PLoS Med. 10 2013 e1001547
22. M. Frye, M.L. Prieto, W.V. Bobo, S. Kung, M. Veldic, R.D. Alarcon, K.M. Moore, D.-S. Choi, J.M. Biernacka, and S.J. Tye Current landscape, unmet needs, and future directions for treatment of bipolar depression J. Affect. Disord. 169 2014 S17 S23
23. R.P. Garay, P.M. Llorca, A.H. Young, A. Hameg, and L. Samalin Bipolar disorder: recent clinical trials and emerging therapies for depressive episodes and maintenance treatment Drug Discov. Today 19 2014 1792 1800
24. A.D. Gigante, B. Lafer, and L.N. Yatham Long-acting injectable antipsychotics for the maintance treatment of bipolar disorder CNS Drugs 26 2012 403 420
25. F.K. Goodwin, and K.R. Jamison Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression second edition 2007 Oxford University Press
26. F. Hardeveld, J. Spijker, R. De Graaf, W.A. Nolen, and A.T.F. Beekman Recurrence of major depressive disorder and its predictors in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS) Psychol. Med. 43 2013 39 48
27. K.M. Holma, I.K. Holma, T.K. Melartin, H.J. Rytsälä, and E.T. Isometsä Long-term outcome of major depressive disorder in psychiatric patients is variable J. Clin. Psychiatry 69 2008 196 205
28. S. Hughes, and D. Cohen Systematic review of long-term studies of drug treated and non-drug treated depression J. Affect. Disord. 118 2009 9 18
29. K.R. Jamison, and H.S. Akiskal Medication compliance in patients with bipolar disorder Psychiatr. Clin. N. Am. 6 1983 175 192
30. R. Joffe, and G. MacQueen Prospective, longitudinal study of percentage of time spent ill in patients with bipolar I or bipolar II disorders Bipolar Disord. 6 2004 62 66
31. L.L. Judd, and H.S. Akiskal Delineating the longitudinal structure of depressive illness: beyond clinical subtypes and duration thresholds Pharmacopsychiatry 33 2000 3 7
32. L.L. Judd, H.S. Akiskal, J.D. Maser, P.J. Zeller, J. Endicott, W. Coryell, M.P. Paulus, J.L. Kunovac, C. Leon, T.I. Mueller, J. Rice, and M.B. Keller Prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders Arch. Gen. Psychiatry 55 1998 694 700
33. L.L. Judd, H.S. Akiskal, P.J. Schettler, J. Endicott, J. Maser, D.A. Solomon, A.C. Leon, J.A. Rice, and M.B. Keller The long-term natural history of the weekly symptomatic status of bipolar I disorder Arch. Gen. Psychiatry 59 2002 530 537
34. L.L. Judd, P.J. Schettler, H.S. Akiskal, J. Maser, W. Coryell, D. Solomon, J. Endicott, and M. Keller Long-term symptomatic status of bipolar I vs. bipolar II disorders Int. J. Neuropsychopharmacol. 6 2003 127 137
35. L.L. Judd, P.J. Schettler, W. Coryell, H.S. Akiskal, and J.G. Fiedorowicz Overt irritability/anger in unipolar major depressive episodes: past and current characteristics and implications for long-term course JAMA Psychiatry 70 2013 1171 1180
36. L.L. Judd, P.J. Schettler, D.A. Solomon, J.D. Maser, W. Coryell, J. Endicott, and H.S. Akiskal Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders J. Affect. Disord. 108 2008 49 58
37. N. Kennedy Longitudinal syndromal and sub-syndromal symptoms after severe depression: 10-year follow-up study Br. J. Psychiatry 184 2004 330 336
38. L.V. Kessing, H.V. Hansen, A. Hvenegaard, E.M. Christensen, C. Gluud, and J. Wetterslev Tratment in a specializd outpatient mood disorder clinic v. standard outpatient treatment in the early course of bipolar disorder: randomized clinical trial Br. J. Psychiatry 202 2013 212 219
39. R. Kupka, L. Altshuler, and W. Nolen Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder1 Bipolar Disord. 9 2007 531 535
40. R.W. Lam, S.H. Kennedy, S. Grigoriadis, R.S. McIntyre, R. Milev, R. Ramasubbu, S.V. Parikh, S.B. Patten, and A.V. Ravindran Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults J. Affect. Disord. 117 2009 S26 S43
41. E. Leclerc, R.B. Mansur, and E. Brietzke Determinants of adherence to treatment in bipolar disorder: comprehensive review J. Affect. Disord. 149 2013 247 252
42. R. Lingam, and J. Scott Treatment non-adherence in affective disorders Acta Psychiatr. Scand. 105 2002 164 172
43. T.K. Melartin, H.J. Rytsälä, U.S. Leskelä, P.S. Lestelä-Mielonen, T.P. Sokero, and E.T. Isometsä Severity and comorbidity predict episode duration and recurrence of DSM-IV major depressive disorder J. Clin. Psychiatry 65 2004 810 819
44. M. Melchior, J.-F. Chastang, A. Leclerc, C. Ribet, and F. Rouillon Low socioeconomic position and depression persistence: longitudinal results from the GAZEL cohort study Psychiatry Res. 177 2010 92 96
45. S. Miller, B. Dell'Osso, and T.A. Ketter Prevalence and burden on bipolar depression J. Affect. Disord. 169 2014 S3 S11
46. D. Montagnier, P. Barberger-Gateau, H. Jacqmin-Gadda, J.-F. Dartigues, M. Rainfray, K. Pérès, N. Lechevallier-Michel, and A. Fourrier-Réglat Evolution of prevalence of depressive symptoms and antidepressant use between 1988 and 1999 in a large sample of older French people: results from the personnes agées quid study J. Am. Geriatr. Soc. 54 2006 1839 1845
47. C.J. Murray, and A.D. Lopez Evidence-based health policy - lessons from the Global Burden of Disease Study Science 274 1996 740 743
48. T.-P. Ng, M. Niti, W.-C. Tan, Z. Cao, K.-C. Ong, and P. Eng Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life Arch. Intern. Med. 167 2007 60 67
49. G. Oepen, P. Salvatore, and R.J. Baldessarini On the periodicity of manic-depressive insanity by Eliot Slater (1938): translation and commentary J. Affect. Disord. 78 2004 1 9
50. U. Osby, L. Brandt, N. Correia, A. Ekbom, and P. Sparén Excess mortality in bipolar and unipolar disorder in Sweden Arch. Gen. Psychiatry 58 2001 844 850
51. I. Pacchiarotti, D.J. Bond, R.J. Baldessarini, W.A. Nolen, H. Grunze, R.W. Licht, R.M. Post, M. Berk, G.M. Goodwin, G.S. Sachs, L. Tondo, R.L. Findling, E.A. Youngstrom, M. Tohen, J. Undurraga, A. González-Pinto, J.F. Goldberg, A. Yildiz, L.L. Altshuler, J.R. Calabrese, P.B. Mitchell, M.E. Thase, A. Koukopoulos, F. Colom, M.A. Frye, G.S. Malhi, K.N. Fountoulakis, G. Vázquez, R.H. Perlis, T.A. Ketter, F. Cassidy, H. Akiskal, J.M. Azorin, M. Valentí, D.H. Mazzei, B. Lafer, T. Kato, L. Mazzarini, A. Martínez-Aran, G. Parker, D. Souery, A. Ozerdem, S.L. McElroy, P. Girardi, M. Bauer, L.N. Yatham, C.A. Zarate, A.A. Nierenberg, B. Birmaher, S. Kanba, R.S. El-Mallakh, A. Serretti, Z. Rihmer, A.H. Young, G.D. Kotzalidis, G.M. MacQueen, C.L. Bowden, S.N. Ghaemi, C. Lopez-Jaramillo, J. Rybakowski, K. Ha, G. Perugi, S. Kasper, J.D. Amsterdam, R.M. Hirschfeld, F. Kapczinski, and E. Vieta International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders Am. J. Psychiatry 170 2013 1249 1262
52. S.V. Parikh, L.D. Hawke, V. Velyvis, A. Zaretsky, S. Beaulieu, I. Patelis-Siotis, G. MacQueen, L.T. Young, L.N. Yatham, and P. Cervantes Combined treatment: impact of optimal psychotherapy and medication in bipolar disorder Bipolar Disord. 2014 1 11
53. E.S. Paykel, R. Abbott, R. Morriss, H. Hayhurst, and J. Scott Sub-syndromal and syndromal symptoms in the longitudinal course of bipolar disorder Br. J. Psychiatry 189 2006 118 123
54. M. Pompili, P. Venturini, M. Palermo, H. Stefani, M.E. Seretti, D.A. Lamis, G. Serafini, M. Amore, and P. Girardi Mood disorders medications: predictors of nonadherence: review of the current literature Expert Rev. Neurother. 13 2013 809 825
55. R.M. Post, K.D. Denicoff, G.S. Leverich, L.L. Altshuler, M.A. Frye, T.M. Suppes, A.J. Rush, P.E. Keck, S.L. McElroy, D.A. Luckenbaugh, C. Pollio, R. Kupka, and W.A. Nolen Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method J. Clin. Psychiatry 64 2003 680 690
56. K.A. Riihimäki, M.S. Vuorilehto, T.K. Melartin, and E.T. Isometsä Five-year outcome of major depressive disorder in primary health care Psychol. Med. 44 2014 1369 1379
57. A. Schaffer, E.T. Isometsä, L. Tondo, D. Moreno, G. Turecki, C. Reis, F. Cassidy, M. Sinyor, J.M. Azorin, L.V. Kessing, K. Ha, T. Goldstein, A. Weizman, A. Beautrais, Y.H. Chou, N. Diazgranados, A.J. Levitt, C.A. Zarate Jr., Z. Rihmer, and L.N. Yatham International Society for Bipolar Disorder Task Force on Suicide: meta-analysis and meta-regressin of correlates of suicide attempts and suicide deaths in biplar disorder Bipolar Disord. 17 2015 1 16
58. F. Seemüller, S. Meier, M. Obermeier, R. Musil, M. Bauer, M. Adli, K. Kronmüller, F. Holsboer, P. Brieger, G. Laux, W. Bender, I. Heuser, J. Zeiler, W. Gaebel, M. Riedel, P. Falkai, and H.-J. Möller Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors Eur. Arch. Psychiatry Clin. Neurosci. 264 2014 567 575
59. V. Selle, S. Schalkwijk, G.H. Vázquez, and R.J. Baldessarini Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics Pharmacopsychiatry 47 2014 43 52
60. A.R. Sutin, A. Terracciano, Y. Milaneschi, Y. An, L. Ferrucci, and A.B. Zonderman The trajectory of depressive symptoms across the adult life span JAMA Psychiatry 70 2013 803 811 doi: 10.1001/jamapsychiatry.2013.193
61. L. Tondo, and R.J. Baldessarini Suicide in bipolar disorder A. Yildiz, C. Nemeroff, P. Ruiz, Bipolar Disorder Millenium Update 2015 Oxford University Press New York
62. L. Tondo, R.J. Baldessarini, G. Vázquez, B. Lepri, and C. Visioli Clinical responses to antidepressants among 1036 acutely depressed patients with bipolar or unipolar major affective disorders Acta Psychiatr. Scand. 127 2013 355 364
63. L. Tondo, B. Lepri, and R.J. Baldessarini Suicidal risks among 2826 Sardinian major affective disorder patients Acta Psychiatr. Scand. 116 2007 419 428
64. J. Undurraga, and R.J. Baldessarini Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review Neuropsychopharmacology 37 2012 851 864
65. T.B. Ustun Global burden of depressive disorders in the year 2000 Br. J. Psychiatry 184 2004 386 392
66. K. Van der Kooy, H. van Hout, H. Marwijk, H. Marten, C. Stehouwer, and A. Beekman Depression and the risk for cardiovascular diseases: systematic review and meta analysis Int. J. Geriatr. Psychiatry 22 2007 613 626
67. E.M. van Weel-Baumgarten, H.J. Schers, W.J. van den Bosch, H.J. van den Hoogen, and F.G. Zitman Long-term follow-up of depression among patients in the community and in family practice settings. A systematic review J. Fam. Pract. 49 2000 1113 1120
68. G. Vázquez, L. Tondo, and R.J. Baldessarini Comparison of antidepressant responses in patients with bipolar vs. unipolar depression: meta-analytic review Pharmacopsychiatry 44 2011 21 26
69. A.C.M. Vergouwen, A. Bakker, W.J. Katon, T.J. Verheij, and F. Koerselman Improving adherence to antidepressants: a systematic review of interventions J. Clin. Psychiatry 64 2003 1415 1420
70. F.K. Vergunst, A. Fekadu, S.C. Wooderson, C.S. Tunnard, L.J. Rane, K. Markopoulou, and A.J. Cleare Longitudinal course of symptom severity and fluctuation in patients with treatment-resistant unipolar and bipolar depression Psychiatry Res. 207 2013 143 149
71. E. Vieta Pros and cons of specialized care in boplar disorder: an international perspective Br. J. Psychiatry 202 2013 170 171
72. World Health Organization (WHO), 2012. Global burden of disease: depression. [Accessible at http://www.who.int/healthinfo/statistics/en/& http://www.who.int/mediacentre/factsheets/fs369/en/].
73. L.R. Wulsin, and B.M. Singal Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review Psychosom. Med. 65 2003 201 210
74. L.N. Yatham, S.H. Kennedy, S.V. Parikh, A. Schaffer, S. Beaulieu, M. Alda, C. O'Donovan, G. Macqueen, R.S. McIntyre, V. Sharma, A. Ravindran, L.T. Young, R. Milev, D.J. Bond, B.N. Frey, B.I. Goldstein, B. Lafer, B. Birmaher, K. Ha, W.A. Nolen, and M. Berk Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013 Bipolar Disord. 15 2013 1 44
75. J. Yiend, E. Paykel, R. Merritt, K. Lester, H. Doll, and T. Burns Long term outcome of primary care depression J. Affect. Disord. 118 2009 79 86
76. A. Yildiz, M. Nikodem, E. Vieta, C.U. Correll, and R.J. Baldessarini A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania Psychol. Med. 2014 1 19